Category Archives: Guest Post

Jonesing on Carbon

A reminder that the rich are grossly dispropirtionate carbon fuel users.

China And U.S. Lock Horns Over New 122.5% Steel Tariff

Yet another US/China trade row, this one over steel.

2:00PM Water Cooler 8/23/2023

~ Today’s Water Cooler ~

The Scourge of Corporate Financialization: Income Inequity, Employment Instability, Productive Fragility

Stock buybacks, aka corporate financialization, as a mode of predatory value extraction

Links 8/23/2023

Ann Pettifor Explains Why Neoclassical Economists Are the Last People To Listen to on Climate Change

A well-warranted takedown of the irresponsible and destructive record of mainstream economists on climate change.

2:00PM Water Cooler 8/22/2023

~ Today’s Water Cooler ~

As Offshore Wind Ramps Up, Scientists Flag Potential Impacts

Offshore wind farms can create their own local climates and may alter currents. How does that affect marine ecosystems?

The Moment of Truth Arrives for Mexico’s Anti-GM Corn Laws

This may be an important battle for Big Ag lobbies and biotech companies but it is an existential one for Mexico, for whom corn is the cornerstone not only of its cuisine and diet but also its culture.

China And Russia Execute A Pincer Movement Around Iraq’s Biggest Oil Assets

China and Russia oil plays in and around Iraq provide further evidence that the US has lost its touch in the hegemony game.

2:00PM Water Cooler 8/21/2023

~ Today’s Water Cooler ~

Stigler Center/ProMarket Hypocrisy: Published, Then Removed Post That Justified Anti-Trust; Bogus Excuses Demonstrate University of Chicago Failed Econowashing of Hard Core Neoclassical Stance

ProMarket and the Consumer Welfare Standard: Output increase is not sufficient to increase welfare. Allocation, aka distribution, matters.

Links 8/20/2023

Memes About Animal Resistance Are Everywhere — Here’s Why You Shouldn’t Laugh off Rebellious Orcas and Sea Otters Too Quickly

Are human and nonhuman animals’ struggles against oppression intertwined?

A Peek at Big Pharma’s Playbook That Leaves Many Americans Unable to Afford Their Drugs

The Biden Adminstration has implemented some modest curbs on drug prices. Big Pharma is fighting a rearguard action in court.